Thursday - March 28, 2024
OU Health Sciences Center Diabetic Retinopathy Research Commercialized to Work Toward New Treatment
May 09, 2020
OKLAHOMA CITY, Oklahoma, May 9 -- The University of Oklahoma's College of Medicine issued the following news:

In people with diabetes, diabetic retinopathy is a frequent complication and the most common cause of vision loss. To curtail the prevalence of the devastating eye disease, University of Oklahoma researchers on both the Oklahoma City and Norman campuses have launched a pharmaceutical company to develop a new treatment.

The company Excitant Therapeutics was forme . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products